RecallDepth
Class II Ongoing

Duloxetine Delayed-Release Capsules, USP, 30 mg, 1,000-count bottle, Rx only, Distributed by: Rising Health, LLC, Saddle Brook, NJ 07663, NDC 57237-018-99

This recall is currently active, issued March 26, 2025. It was issued by Rising Pharma Holding, Inc..

Company
Rising Pharma Holding, Inc.
Recall Initiated
March 5, 2025
Posted
March 26, 2025
Recall Number
D-0277-2025
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
1223 bottles
Firm Location
East Brunswick, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit.

Distribution

Nationwide in the USA.

Lot / Code Info

Lot #: DTB23111A, Exp 8/31/2025

More recalls by Rising Pharma Holding, Inc.

View all recalls by this company →

Other recent Class II Drug recalls